Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by tdon1229on Mar 19, 2020 5:53pm

90 Views

Post# 30828346

RE:RE:RE:RE:RE:RE:I rest my case on the US Federal Bureaucracy

Vestor,

What's pathetic is the fake news reporting. Trump merely stated that the FDA approved chloroquine for testing specifically for efficacy vis-a-vis COVID-19. He did not say it was FDA-approved for general use.

It has been in use for decades as treatment for malaria, auto-immune diseases, and in some cases for arthritis. Whoever wrote the news update was in error when he said the FDA spokesman contradicted the president's claim since he made no such claim.

Note there is another possible serious side effect from the use of chloroquine and that is QT prolongation which can lead to heart rhythm problems.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario